Vitreoretinal Surgery in Uveitis: From Old to New Concepts - A Review

References

• Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121(12):2387–2392. doi:10.1016/j.ophtha.2014.07.007.
   PubMed Web of Science ®Google Scholar
• Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko E, Foster CS. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Ocul Immunol Inflamm. 2010;18(5):411–417. doi:10.3109/09273948.2010.501132.
   PubMed Web of Science ®Google Scholar
• Belmont JB, Michelson JB. Vitrectomy in uveitis associated with ankylosing spondylitis. Am J Ophthalmol. September, 1982;94(3):300–304. doi:10.1016/0002-9394(82)90354-3.
   PubMed Web of Science ®Google Scholar
• Nolthenius T, Deutman AF. Surgical treatment of the complications of chronic uveitis. Ophthalmologica. 1983;186(1):11–16. doi:10.1159/000309254.
   PubMed Web of Science ®Google Scholar
• Algvere P, Alanko H, Dickhoff K, Lähde Y, Saari KM. Pars plana vitrectomy in the management of intraocular inflammation. Acta Ophthalmol. October, 1981;59(5):727–736. doi:10.1111/j.1755-3768.1981.tb08739.x.
   Web of Science ®Google Scholar
• Machemer R, Parel JM, Norton EW. Vitrectomy: a pars plana approach. Technical improvements and further results. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:462–466.
   PubMedGoogle Scholar
• Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140(6):1096–1105. doi:10.1016/j.ajo.2005.07.017.
   PubMed Web of Science ®Google Scholar
• Belmont JB, Irvine A, Benson W, O’connor GR. Vitrectomy in ocular toxocariasis. Arch Ophthalmol. December 1, 1982;100(12):1912–1915. doi:10.1001/archopht.1982.01030040892004.
   PubMedGoogle Scholar
• Eichenbaum DM, Jaffe NS, Clayman HM, Light DS. Pars plana vitrectomy as a primary treatment for acute bacterial endophthalmitis. Am J Ophthalmol. August, 1978;86(2):167–171. doi:10.1016/S0002-9394(14)76806-0.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Raichand M, Bennett TO. Management of endophthalmitis with pars plana vitrectomy. British J Ophthalmol. July 1, 1980;64(7):472–475. doi:10.1136/bjo.64.7.472.
   PubMed Web of Science ®Google Scholar
• Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978;96(10):1798–1804. doi:10.1001/archopht.1978.03910060310002.
   PubMedGoogle Scholar
• Smith RE, Kokoris N, Nobe JR, Diddie KR, Cherney EF. Lensectomy-vitrectomy in chronic uveitis. Trans Am Ophthalmol Soc. 1983;81:261–275.
   PubMedGoogle Scholar
• Flynn HW, Dams JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. August, 1988;95(8):1114–1119. doi:10.1016/S0161-6420(88)33051-4.
   PubMed Web of Science ®Google Scholar
• Dangel ME, Stark WJ, Michels RG. Surgical management of cataract associated with chronic uveitis. Ophthalmic Surg. February, 1983;14(2):145–149. doi:10.3928/1542-8877-19830201-06.
   PubMedGoogle Scholar
• Engel HM, Green RW, Michels RG, Rice TA, Erozan YS. Diagnostic vitrectomy. Retina. 1981;1(2):121–149. doi:10.1097/00006982-198101020-00009.
   PubMedGoogle Scholar
• Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003;241(10):860–870. doi:10.1007/s00417-003-0749-y.
   PubMed Web of Science ®Google Scholar
• Mruthyunjaya P, Jumper JM, McCallum R, Patel DJ, Cox TA, Jaffe GJ. Diagnostic yield of vitrectomy in eyes with suspected posterior segment infection or malignancy. Ophthalmology. 2002;109(6):1123–1129. doi:10.1016/S0161-6420(02)01033-3.
   PubMed Web of Science ®Google Scholar
• Leuenberger P. L’intérêt de la vitrectomie dans le traitement des uvéites postérieures. Klin Monbl Augenheilkd. May 11, 1984;184(05):445–448. doi:10.1055/s-2008-1054518.
   PubMedGoogle Scholar
• Aylward GW. The place of vitreoretinal surgery in the treatment of macular oedema. Documenta Ophthalmologica. 1999;97(3/4):433–438. doi:10.1023/A:1002456105652.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Bornfeld N, Wessing A. Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol. 1996;7(3):77–79. doi:10.1097/00055735-199606000-00013.
   PubMedGoogle Scholar
• Heiligenhaus A, Bornfeld N, Foerster MH, Wessing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. British J Ophthalmol. 1994;78(7):549–554. doi:10.1136/bjo.78.7.549.
   PubMed Web of Science ®Google Scholar
• Wiechens B, Nölle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239(7):474–481. doi:10.1007/s004170100254.
   PubMed Web of Science ®Google Scholar
• Androudi S, Ahmed M, Fiore T, Brazitikos P, Foster CS. Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg. 2005;31(3):472–478. doi:10.1016/j.jcrs.2004.06.040.
   PubMed Web of Science ®Google Scholar
• Dugel PU, Rao NA, Ozler S, Liggett PE, Smith RE. Pars plana vitrectomy for intraocular inflammation-related cystold macular edema unresponsive to corticosteroids a preliminary study. Ophthalmology. 1992;99(10). doi:10.1016/S0161-6420(92)31769-5.
   Web of Science ®Google Scholar
• Kaplan HJ. Surgical treatment of intermediate uveitis. Dev Ophthalmol. 1992;23:185–189. doi:10.1159/000429650.
   PubMedGoogle Scholar
• Freyler H, Velikay M. Vitrektomie bei Uveitis. Klin Monbl Augenheilkd. October 11, 1984;185(10):263–267. doi:10.1055/s-2008-1054611.
   PubMedGoogle Scholar
• Liversidge J, Dick A, Cheng YF, Scott GB, Forrester JV. Retinal antigen specific lymphocytes, Tcr-Gamma Delta T Cells and Cd5 + B Cells cultured from the vitreous in acute sympathetic ophthalmitis. Autoimmunity. January 7, 1993;15(4):257–266. doi:10.3109/08916939309115747.
   PubMed Web of Science ®Google Scholar
• Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Dis. 1999;16(1):24-31.
   Web of Science ®Google Scholar
• Muhaya M, Calder VL, Towler HMA, Jolly G, McLauchlan M, Lightman S. Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol. 1999;116(3):410–414. doi:10.1046/j.1365-2249.1999.00921.x.
   PubMed Web of Science ®Google Scholar
• Eckardt C, Bacskulin A. Vitrectomy in intermediate uveitis 1992;23: 232–238.
   Google Scholar
• Heimann K, Schmanke L, Brunner R, Amerian B. Pars plana vitrectomy in the treatment of chronic uveitis. 1992;23:196–203.
   Google Scholar
• Tranos P, Scott R, Zambarajki H, Ayliffe W, Pavesio C, Charteris D. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study. British J Ophthalmol. 2006;90(9):1107–1110. doi:10.1136/bjo.2006.092965.
   PubMed Web of Science ®Google Scholar
• Shalaby O, Saeed A, Elmohamady MN. Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study. Arq Bras Oftalmol. 2020;83(5). doi:10.5935/0004-2749.20200079.
   PubMed Web of Science ®Google Scholar
• Soylu M, Demircan N, Pelit A. Pars plana vitrectomy in ocular Behçet’s disease. Int Ophthalmol. 2001;24:219–223.
   PubMedGoogle Scholar
• Foster CS. Vitrectomy in the management of uveitis. Ophthalmology. August, 1988;95(8):1011–1012. doi:10.1016/S0161-6420(88)33062-9.
   PubMed Web of Science ®Google Scholar
• Dick AD. The treatment of chronic uveitic macular oedema. British J Ophthalmol. 1994;78(1):1–2. doi:10.1136/bjo.78.1.1.
   PubMed Web of Science ®Google Scholar
• Karim R, Tang B. Use of antivascular endothelial growth factor for diabetic macular edema. Clin Ophthalmol. 2010;4(1):493. doi:10.2147/OPTH.S8980.
   PubMedGoogle Scholar
• Li YH, Hsu SL, Sheu SJ. A review of local therapy for the management of cystoid macular edema in uveitis. Asia-Pac J Ophthalmol. 2021;10(1):87–92. doi:10.1097/APO.0000000000000352.
   PubMed Web of Science ®Google Scholar
• Hikichi T, Trempe CL. Role of the vitreous in the prognosis of peripheral uveitis. Am J Ophthalmol. 1993;116(4):401–405. doi:10.1016/S0002-9394(14)71395-9.
   PubMed Web of Science ®Google Scholar
• Karim R, Sykakis E, Lightman S, Fraser-Bell S. Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol. 2013;7:1109. doi:10.2147/OPTH.S40268.
   PubMedGoogle Scholar
• Ossewaarde-Van Norel A, Rothova A. Clinical review: update on treatment of inflammatory macular edema. Ocul Immunol Inflammation. 2011;19(1):75–83. doi:10.3109/09273948.2010.509530.
   PubMed Web of Science ®Google Scholar
• Choudhry S, Ghosh S. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema. Clin Exp Ophthalmol. 2007;35(8):713–718. doi:10.1111/j.1442-9071.2007.01578.x.
   PubMed Web of Science ®Google Scholar
• Gutfleisch M, Spital G, Mingels A, Pauleikhoff D, Lommatzsch A, Heiligenhaus A. Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations. British J Ophthalmol. 2007;91(3):345–348. doi:10.1136/bjo.2006.101675.
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Enaida H, Ueno A, et al. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. British J Ophthalmol. 2003;87(8):1010–1014. doi:10.1136/bjo.87.8.1010.
   PubMed Web of Science ®Google Scholar
• Henry CR, Becker MD, Yang Y, Davis JL. Pars plana vitrectomy for the treatment of uveitis. Am J Ophthalmol. 2018;190:142–149. doi:10.1016/j.ajo.2018.03.031.
   PubMed Web of Science ®Google Scholar
• Tanawade RG, Tsierkezou L, Bindra MS, Patton NA, Jones NP. Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis. Retina. 2015;35(4):736–741. doi:10.1097/IAE.0000000000000378.
   PubMed Web of Science ®Google Scholar
• Liu T, Bi H, Wang X, Gao Y, Wang G, Ma W. Macular abnormalities in Chinese patients with uveitis. Optometry and Vision Sci. 2015;92(8):858–862. doi:10.1097/OPX.0000000000000645.
   PubMed Web of Science ®Google Scholar
• Nicholson BP, Zhou M, Rostamizadeh M, et al. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121(12):2393–2398. doi:10.1016/j.ophtha.2014.06.015.
   PubMed Web of Science ®Google Scholar
• Yazici AT, Alagöz N, Çelik HU, et al. Idiopathic and secondary epiretinal membranes: do they differ in terms of morphology? An optical coherence tomography-based study. Retina. 2011;31(4):779–784. doi:10.1097/IAE.0b013e3181ef8786.
   PubMed Web of Science ®Google Scholar
• Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999;106(6):1086–1090. doi:10.1016/S0161-6420(99)90247-6.
   PubMed Web of Science ®Google Scholar
• Soheilian M, Ramezani A, Soheilian R. 25-gauge vitrectomy for complicated chronic endogenous/autoimmune uveitis: predictors of outcomes. Ocul Immunol Inflamm. 2013;21(2):93–101. doi:10.3109/09273948.2012.734536.
   PubMed Web of Science ®Google Scholar
• Sheybani A, Harocopos GJ, Rao PK. Immunohistochemical study of epiretinal membranes in patients with uveitis. J Ophthalmic Inflamm Infect. 2012;2(4):243–248. doi:10.1007/s12348-012-0074-x.
   PubMedGoogle Scholar
• Aaberg TM, Cesarz TJ, Flickinger RR. Treatment of peripheral uveoretinitis by cryotherapy. Am J Ophthalmol. April, 1973;75(4):685–688. doi:10.1016/0002-9394(73)90821-0.
   PubMed Web of Science ®Google Scholar
• Aaberg TM, Devenyi RG, Mieler WF, Lambrou FH, Will BR. Cryopexy of the vitreous base in the management of peripheral uveitis. Am J Ophthalmol. August, 1988;106(2):135–138. doi:10.1016/0002-9394(88)90824-0.
   PubMed Web of Science ®Google Scholar
• Josephberg RG, Kanter ED, Jaffee RM. A fluorescem angiographic study of patients with pars planitis and peripheral exudation (snowbanking) before and after cryopexy. Ophthalmology. July, 1994;101(7):1262–1266. doi:10.1016/S0161-6420(13)31726-6.
   PubMed Web of Science ®Google Scholar
• Sohn EH, Chaon BC, Jabs DA, Folk JC. Peripheral cryoablation for treatment of active pars planitis: long-term outcomes of a retrospective study. Am J Ophthalmol. February, 2016;162:35–42.e2. doi:10.1016/j.ajo.2015.11.009.
   PubMed Web of Science ®Google Scholar
• Kiryu J. Pars plana vitrectomy for epiretinal membrane associated with sarcoidosis. Jpn J Ophthalmol. October, 2003;47(5):479–483. doi:10.1016/S0021-5155(03)00128-X.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB. Macular alterations secondary to intraocular inflammatory disease. Ophthalmology. 1986;93(7):984–988. doi:10.1016/S0161-6420(86)33654-6.
   PubMed Web of Science ®Google Scholar
• Bonnin N, Cornut PL, Chaise F, et al. Spontaneous closure of macular holes secondary to posterior uveitis: case series and a literature review. J Ophthalmic Inflamm Infect. 2013;3(1):34. doi:10.1186/1869-5760-3-34.
   PubMedGoogle Scholar
• Branson SV, McClafferty BR, Kurup SK. Vitrectomy for epiretinal membranes and macular holes in uveitis patients. J Ocul Pharmacol Ther. May, 2017;33(4):298–303. doi:10.1089/jop.2016.0142.
   PubMed Web of Science ®Google Scholar
• Soliman MK, Tohamy DM, Sallam AB, Tabbaa T, Kurup SK. Treatment outcomes of macular holes in the setting of uveitis: a scoping review. Graefes Arch Clin Exp Ophthalmol. July 17, 2022;260(7):2079–2086. doi:10.1007/s00417-022-05590-0.
   PubMed Web of Science ®Google Scholar
• Gregory ME, Bhatt U, Benskin S, Banerjee S. Bilateral full thickness macular holes in association with serpiginous choroiditis macular holes in serpiginous choroiditis. Ocul Immunol Inflamm. 2009;17(5):328–329. doi:10.3109/09273940903105128.
   PubMed Web of Science ®Google Scholar
• Smiddy WE, Flynn HW. Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol. 2004;137(3):525–537. doi:10.1016/j.ajo.2003.12.011.
   PubMed Web of Science ®Google Scholar
• Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109(5):654. doi:10.1001/archopht.1991.01080050068031.
   PubMedGoogle Scholar
• Madi HA, Masri I, Steel DH. Optimal management of idiopathic macular holes. Clin Ophthalmol. 2016;10:97–116. doi:10.2147/OPTH.S96090.
   PubMed Web of Science ®Google Scholar
• Alsarhani WK, Saifaldein AA, Abu El-Asrar AM. A novel mechanism of macular holes in patients with Behçet’s uveitis. Saudi J Ophthalmol. 2022;36(4):394–396. doi:10.4103/sjopt.sjopt_102_21.
   PubMed Web of Science ®Google Scholar
• Tanaka R, Obata R, Sawamura H, Ohtomo K, Kaburaki T. Temporal changes in a giant macular hole formed secondary to toxoplasmic retinochoroiditis. Can J Ophthalmol. October, 2014;49(5):e115–8. doi:10.1016/j.jcjo.2014.06.006.
   PubMed Web of Science ®Google Scholar
• Al-Dhibi H, Abouammoh M, Al-Harthi E, et al. Macular hole in Behçet′s disease. Indian, J Ophthalmol. 2011;59(5):359. doi:10.4103/0301-4738.83611.
   PubMed Web of Science ®Google Scholar
• Cui Y, Wang G, Li Y, Wang Y, Wang X, Bi H. Optical coherence tomography and histopathology of macular uveitis. Optometry and Vision Sci. 2014;91(11). doi:10.1097/OPX.0000000000000399.
   Web of Science ®Google Scholar
• Panos GD, Papageorgiou E, Kozeis N, Gatzioufas Z. Macular hole formation after toxoplasmic retinochoroiditis. BMJ Case Rep. 2013;2013(mar06 1):bcr2013008915. doi:10.1136/bcr-2013-008915.
   PubMedGoogle Scholar
• Kelly NE. Vitreous surgery for idiopathic macular holes. Arch Ophthalmol. May 1, 1991;109(5):654. doi:10.1001/archopht.1991.01080050068031.
   PubMedGoogle Scholar
• Kobayashi I, Inoue M, Okada AA, Keino H, Wakabayashi T, Hirakata A. Vitreous surgery for macular hole in patients with Vogt-Koyanagi-Harada disease. Clin Exp Ophthalmol. December 2008;36(9):861–864. doi:10.1111/j.1442-9071.2008.01903.x.
   PubMed Web of Science ®Google Scholar
• Gregory ME, Bhatt U, Benskin S, Banerjee S. Bilateral full thickness macular holes in association with serpiginous choroiditis. Ocul Immunol Inflamm. October 15, 2009;17(5):328–329. doi:10.3109/09273940903105128.
   PubMed Web of Science ®Google Scholar
• Woo SJ, Yu HG, Chung H. Surgical outcome of vitrectomy for macular hole secondary to uveitis. Acta Ophthalmol. 2010;88(7):e287–288. doi:10.1111/j.1755-3768.2009.01667.x.
   PubMed Web of Science ®Google Scholar
• Kahloun R, Ben Yahia S, Mbarek S, Attia S, Zaouali S, Khairallah M. Macular involvement in patients with Behçet’s uveitis. J Ophthalmic Inflamm Infect. September 2, 2012;2(3):121–124. doi:10.1007/s12348-012-0075-9.
   PubMedGoogle Scholar
• Sousa DC, de Andrade GC, Nascimento H, Maia A, Muccioli C. Macular hole associated with toxoplasmosis: a surgical case series. Retin Cases Brief Rep. March, 2021;15(2):110–113. doi:10.1097/ICB.0000000000000757.
   PubMedGoogle Scholar
• Hirano M, Morizane Y, Kawata T, et al. Case report: successful closure of a large macular hole secondary to uveitis using the inverted internal limiting membrane flap technique. BMC Ophthalmol. December 25, 2015;15(1):83. doi:10.1186/s12886-015-0072-5.
   PubMedGoogle Scholar
• Callaway NF, Gonzalez MA, Yonekawa Y, et al. Outcomes of pars plana vitrectomy for macular hole in patients with uveitis. Retina. September, 2018;38(1):S41–8. doi:10.1097/IAE.0000000000001942.
   PubMedGoogle Scholar
• Halkiadakis I, Pantelia E, Giannakopoulos N, Koutsandrea C, Markomichelakis NN. Macular hole closure after peribulbar steroid injection. Am J Ophthalmol. December, 2003;136(6):1165–1167. doi:10.1016/S0002-9394(03)00668-8.
   PubMed Web of Science ®Google Scholar
• de Bustros S. Retinal detachment: principles and practice. Retina. 1996;16(5):458–459. doi:10.1097/00006982-199616050-00022.
   Google Scholar
• Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A. Retinal detachment in ocular toxoplasmosis. Ophthalmology. 2000;107(1):36–40. doi:10.1016/S0161-6420(99)00013-5.
   PubMed Web of Science ®Google Scholar
• Rowe JA, Erie JC, Baratz KH, et al. Retinal detachment in Olmsted County, Minnesota, 1976 through 1995. Ophthalmology. 1999;106(1):154–159. doi:10.1016/S0161-6420(99)90018-0.
   PubMed Web of Science ®Google Scholar
• Wilkes SR, Beard CM, Kurland LT, Robertson DM, O’fallon WM. The incidence of retinal detachment in Rochester, Minnesota, 1970—1978. Am J Ophthalmol. 1982;94(5):670–673. doi:10.1016/0002-9394(82)90013-7.
   PubMed Web of Science ®Google Scholar
• Clarkson JG, Blumenkranz MS, Culbertson WW, Flynn HW, Lou LM. Retinal detachment following the acute retinal necrosis syndrome. Ophthalmology. 1984;91(12):1665–1668. doi:10.1016/S0161-6420(84)34107-0.
   PubMed Web of Science ®Google Scholar
• Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–292. doi:10.1016/S0039-6257(05)80105-5.
   PubMed Web of Science ®Google Scholar
• Hagler WS, Jarrett WH, Chang M. Rhegmatogenous retinal detachment following chorioretinal inflammatory disease. Am J Ophthalmol. 1978;86(3):373–379. doi:10.1016/0002-9394(78)90242-8.
   PubMed Web of Science ®Google Scholar
• Kerkhoff FT, Lamberts QJ, van den Biesen PR, Rothova A. Rhegmatogenous retinal detachment and uveitis. Ophthalmology. 2003;110(2):427–431. doi:10.1016/S0161-6420(02)01744-X.
   PubMed Web of Science ®Google Scholar
• Weber-Krause B, Eckardt C. Häufigkeit einer hinteren Glaskörperabhebung im Alter. Der Ophthalmologe. 1997;94(9):619–623. doi:10.1007/s003470050170.
   PubMedGoogle Scholar
• Yonemoto J, Ideta H, Sasaki K, Tanaka S, Hirose A, Oka C. The age of oneset of posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol. 1994;232(2):67–70. doi:10.1007/BF00171665.
   PubMed Web of Science ®Google Scholar
• De Hoog J, Ten Berge JC, Groen F, Rothova A. Rhegmatogenous retinal detachment in uveitis. J Ophthalmic Inflamm Infect. December 21, 2017;7(1):22. doi:10.1186/s12348-017-0140-5.
   PubMedGoogle Scholar
• Li JQ, Welchowski T, Schmid M, Holz FG, Finger RP. Incidence of rhegmatogenous retinal detachment in europe – a systematic review and meta-analysis. Ophthalmologica. 2019;242(2):81–86. doi:10.1159/000499489.
   PubMed Web of Science ®Google Scholar
• Davis JL. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV Infection. Arch Ophthalmol. November 1, 1995;113(11):1401. doi:10.1001/archopht.1995.01100110061026.
   PubMedGoogle Scholar
• Charteris DG. Surgical management of HIV related retinal detachment. British J Ophthalmol. March 1, 1997;81(3):177–178. doi:10.1136/bjo.81.3.177.
   PubMed Web of Science ®Google Scholar
• Muccioli C, Belfort R Jr. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Braz J Med Biol Res. July, 2000;33(7):779–789. doi:10.1590/S0100-879X2000000700008.
   PubMed Web of Science ®Google Scholar
• Dowler JG, Towler HM, Mitchell SM, Cooling RJ, Lightman SL. Retinal detachment and herpesvirus retinitis in patients with AIDS. British J Ophthalmol. June 1, 1995;79(6):575–580. doi:10.1136/bjo.79.6.575.
   PubMed Web of Science ®Google Scholar
• Han DP, Lewis H, Williams GA, Mieler WF, Abrams GW, Aaberg TM. Laser photocoagulation in the acute retinal necrosis syndrome. Arch Ophthalmol. 1987;105(8):1051–1054. doi:10.1001/archopht.1987.01060080053027.
   PubMedGoogle Scholar
• Sternberg P, Han DP, Yeo JH, et al. Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology. 1988;95(10):1389–1393. doi:10.1016/S0161-6420(88)32999-4.
   PubMed Web of Science ®Google Scholar
• Blumenkranz MS, Culbertson WW, Clarkson JG, Dix R. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology. 1986;93(3):296–300. doi:10.1016/S0161-6420(86)33740-0.
   PubMed Web of Science ®Google Scholar
• Fan S, Lin D, Wang Y. Role of prophylactic vitrectomy in acute retinal necrosis in preventing rhegmatogenous retinal detachment: systematic review and meta-analysis. Ocul Immunol Inflamm. February 17, 2022;30(2):515–519. doi:10.1080/09273948.2020.1800051.
   PubMed Web of Science ®Google Scholar
• Haug SJ, Takakura A, Jumper JM, et al. Rhegmatogenous retinal detachment in patients with acute syphilitic panuveitis. Ocul Immunol Inflamm. January 2, 2016;24(1):69–76. doi:10.3109/09273948.2014.925122.
   PubMed Web of Science ®Google Scholar
• Williamson TH, Shunmugam M, Rodrigues I, Dogramaci M, Lee E. Characteristics of rhegmatogenous retinal detachment and their relationship to visual outcome. Eye. September 21, 2013;27(9):1063–1069. doi:10.1038/eye.2013.136.
   PubMed Web of Science ®Google Scholar
• Hui YN, Sorgente N, Ryan SJ. Posterior vitreous separation and retinal detachment induced by macrophages. Graefes Arch Clin Exp Ophthalmol. 1987;225(4):279–284. doi:10.1007/BF02150149.
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta A, Gupta V, et al. Safety and outcome of microincision vitreous surgery in uveitis. Ocul Immunol Inflamm. November 2, 2017;25(6):775–784. doi:10.3109/09273948.2016.1165259.
   PubMed Web of Science ®Google Scholar
• Bansal R, Dogra M, Chawla R, Kumar A. Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery. Indian, J Ophthalmol. 2020;68(9):1844. doi:10.4103/ijo.IJO_1625_20.
   PubMed Web of Science ®Google Scholar
• Fujii GY, de Juan E, Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery1 1the new transconjunctival sutureless vitrectomy system is disclosed to Bausch & Lomb Surgical, St. Louis, MO. The Microsurgery Advanced Design Laboratory (MADLAB) may receive royalties related to the sale of this and other instruments mentioned in the article. Ophthalmology. October, 2002;109(10):1814–1820. doi:10.1016/s0161-6420(02)01119-3.
   PubMed Web of Science ®Google Scholar
• Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina. February, 2005;25(2):208–211. doi:10.1097/00006982-200502000-00015.
   PubMed Web of Science ®Google Scholar
• Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27–gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology. January, 2010;117(1):93–102.e2. doi:10.1016/j.ophtha.2009.06.043.
   PubMed Web of Science ®Google Scholar
• Moharana B, Dogra M, Tigari B, et al. Outcomes of 25-gauge pars plana vitrectomy for cytomegalovirus retinitis-related retinal detachment. Indian, J Ophthalmol. 2021;69(9):2361. doi:10.4103/ijo.IJO_3539_20.
   PubMed Web of Science ®Google Scholar
• Moharana B, Dogra M, Singh S, et al. Outcomes of 25-gauge pars plana vitrectomy with encircling scleral band for acute retinal necrosis-related rhegmatogenous retinal detachment. Indian, J Ophthalmol. 2021;69(3):635. doi:10.4103/ijo.IJO_1353_20.
   PubMed Web of Science ®Google Scholar
• García RF, Flores-Aguilar M, Quiceno JI, et al. Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology. February, 1995;102(2):236–245. doi:10.1016/S0161-6420(95)31030-5.
   PubMed Web of Science ®Google Scholar
• Pederson JE. Ocular hypotony. Trans Ophthalmol Soc U K. 1986;105:220–226.
   PubMedGoogle Scholar
• Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. March, 1987;28(3):477–481.
   PubMed Web of Science ®Google Scholar
• Mermoud A, Baerveldt G, Minckler D, Rao N. Prostaglandines E2 et E2-α au cours du Glaucome Uvéitique chez le rat Lewis. Klin Monbl Augenheilkd. May 24, 1995;206(5):409–412. doi:10.1055/s-2008-1035477.
   PubMedGoogle Scholar
• de Smet MD, Gunning F, Feenstra R, de Smet MD. The surgical management of chronic hypotony due to uveitis. Eye. January 20, 2005;19(1):60–64. doi:10.1038/sj.eye.6701425.
   PubMed Web of Science ®Google Scholar
• Hirokawa H, Takahashi M, Trempe CL. Vitreous changes in peripheral uveitis. Arch Ophthalmol. 1985;103(11):1704–1707. doi:10.1001/archopht.1985.01050110098035.
   PubMedGoogle Scholar
• Webster L, Stanbury RM, Chignell AH, Limb GA. Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment. Br J Ophthalmol. 1998;82(4):438–443. doi:10.1136/bjo.82.4.438.
   PubMed Web of Science ®Google Scholar
• Capeans C, Lorenzo J, Santos L, et al. Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 1998;236(7):481–485. doi:10.1007/s004170050109.
   PubMed Web of Science ®Google Scholar
• Limb GA, Chignell AH. Vitreous levels of intracellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy. Br J Ophthalmol. 1999;83(8):953–956. doi:10.1136/bjo.83.8.953.
   PubMed Web of Science ®Google Scholar
• Benner JD, Dao D, Butler JW, Hamill KI. Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy. BMJ Open Ophthalmol. 2019;4(1):e000293. doi:10.1136/bmjophth-2019-000293.
   PubMed Web of Science ®Google Scholar
• Zhao XY, Xia S, Wang EQ, Chen YX. Efficacy of intravitreal injection of bevacizumab in vitrectomy for patients with proliferative vitreoretinopathy retinal detachment: a meta-analysis of prospective studies. Retina. 2018;38(3):462–470. doi:10.1097/IAE.0000000000001584.
   PubMed Web of Science ®Google Scholar
• Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy. a randomized clinical trial. Ophthalmology. 2008;115(11):1938–1943. doi:10.1016/j.ophtha.2008.05.016.
   PubMed Web of Science ®Google Scholar
• Kwon OW, Song JH, Roh MI. Retinal detachment and proliferative vitreoretinopathy. Dev Ophthalmol. 2015;55:154–62.
   PubMedGoogle Scholar
• Wiedemann P, Hilgers RD, Bauer P, Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Am J Ophthalmol. 1998;126(4):550–559. doi:10.1016/S0002-9394(98)00115-9.
   PubMed Web of Science ®Google Scholar
• Asaria RHY, Kon CH, Bunce C, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology. 2001;108(7):1179–1183. doi:10.1016/S0161-6420(01)00589-9.
   PubMed Web of Science ®Google Scholar
• Wickham L, Bunce C, Wong D, McGurn D, Charteris DG. Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology. 2007;114(4):698–704. doi:10.1016/j.ophtha.2006.08.042.
   PubMed Web of Science ®Google Scholar
• Garcia RA, Sanchez JG, Arevalo JF. Combined 5-fluorouracil, low-molecular–weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C. Ophthalmic Surg Lasers Imaging. 2007;38(4):276–282. doi:10.3928/15428877-20070701-02.
   PubMedGoogle Scholar
• Pennock S, Rheaume MA, Mukai S, Kazlauskas A. A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. Am J Pathol. 2011;179(6):2931–2940. doi:10.1016/j.ajpath.2011.08.043.
   PubMed Web of Science ®Google Scholar
• Ophir A, Blumenkranz MS, Claflin AJ. Experimental intraocular proliferation and neovascularization. Am J Ophthalmol. 1982;94(4):450–457. doi:10.1016/0002-9394(82)90238-0.
   PubMed Web of Science ®Google Scholar
• Lei H, Rhéaume MA, Velez G, Mukai S, Kazlauskas A. Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells. Invest Ophthalmol Vis Sci. August 24, 2011;52(9):5016–5021. doi:10.1167/iovs.11-7442. PMID: 21642621; PMCID: PMC3176061.
   PubMed Web of Science ®Google Scholar
• I M, O MS, C CA, S MJ. Outcomes of diagnostic and therapeutic vitrectomy in uveitis. Invest Ophthalmol Vis Sci. 2017;58(8):2814–2814.
   Web of Science ®Google Scholar
• Sato T, Kinoshita R, Taguchi M, et al. Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies. Medicine. Medicine (United States). 2018;97(2):e9491. doi:10.1097/MD.0000000000009491.
   PubMed Web of Science ®Google Scholar
• Abi-Ayad N, Grange JD, Salle M, Kodjikian L. Transretinal uveal melanoma biopsy with 25-gauge vitrectomy system. Acta Ophthalmol. 2013;91(3):279–281. doi:10.1111/j.1755-3768.2011.02172.x.
   PubMed Web of Science ®Google Scholar
• Kanavi MR, Soheilian M, Bijanzadeh B, Peyman GA. Diagnostic vitrectomy (25-gauge) in a case with intraocular lymphoma masquerading as bilateral granulomatous panuveitis. Eur J Ophthalmol. 2010;20(4):795–798. doi:10.1177/112067211002000426.
   PubMed Web of Science ®Google Scholar
• Kinoshita Y, Takasu K, Adachi Y, et al. Diagnostic utility of vitreous humor fluid cytology for intraocular sarcoidosis: a clinicopathologic study of 7 cases. Diagn Cytopathol. 2012;40(3):210–213. doi:10.1002/dc.21540.
   PubMed Web of Science ®Google Scholar
• Sugita S, Shimizu N, Watanabe K, et al. Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. British J Ophthalmol. 2008;92(7):928–932. doi:10.1136/bjo.2007.133967.
   PubMed Web of Science ®Google Scholar
• Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis, features, management, and outcomes. Ophthalmology. 2007;114(4):756–762.e1. doi:10.1016/j.ophtha.2006.08.037.
   PubMed Web of Science ®Google Scholar
• Margolis R. Diagnostic vitrectomy for the diagnosis and management of posterior uveitis of unknown etiology. Curr Opin Ophthalmol. May, 2008;19(3):218–224. doi:10.1097/ICU.0b013e3282fc261d.
   PubMed Web of Science ®Google Scholar
• Tamai M. A collection system to obtain vitreous humor in clinical cases. Arch Ophthalmol. April 1, 1991;109(4):465. doi:10.1001/archopht.1991.01080040025009.
   PubMedGoogle Scholar
• Tsui I, Schwartz SD, Hubschman JP. A current method to collect an undiluted vitrectomy sample. Retina. May, 2010;30(5):830–831. doi:10.1097/IAE.0b013e3181d375ac.
   PubMed Web of Science ®Google Scholar
• Cassoux N, Charlotte F, Rao NA, Bodaghi B, Merle-Beral H, Lehoang P. Endoretinal biopsy in establishing the diagnosis of uveitis: a clinicopathologic report of three cases. Ocul Immunol Inflamm. 2005;13(1):51–55. doi:10.1080/09273940590909149.
   PubMed Web of Science ®Google Scholar
• Johnston R. Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin. Ophthalmology. March, 2004;111(3):522–528. doi:10.1016/j.ophtha.2002.10.002.
   PubMed Web of Science ®Google Scholar
• Cole CJ, Kwan AS, Laidlaw DAH, Aylward GW. A new technique of combined retinal and choroidal biopsy. British J Ophthalmol. October 1, 2008;92(10):1357–1360. doi:10.1136/bjo.2008.141697.
   PubMed Web of Science ®Google Scholar
• Grewal DS, Cummings TJ, Mruthyunjaya P. Outcomes of 27-gauge vitrectomy-assisted choroidal and subretinal biopsy. Ophthalmic Surg Lasers Imaging Retina. May, 2017;48(5):406–415. doi:10.3928/23258160-20170428-07.
   PubMed Web of Science ®Google Scholar
• Tang PH, Shields RA, Mruthyunjaya P, Schefler AC. Biopsy of a choroidal melanoma using transvitreal pars plana vitrectomy. Ophthalmic Surg Lasers Imaging Retina. August, 2018;49(8):645–647. doi:10.3928/23258160-20180803-16.
   PubMed Web of Science ®Google Scholar
• Kvanta A, Seregard S, Kopp ED, All-Ericsson C, Landau I, Berglin L. Choroidal biopsies for intraocular tumors of indeterminate origin. Am J Ophthalmol. December, 2005 ;140(6):1002–1006. doi:10.1016/j.ajo.2005.06.025.
   PubMed Web of Science ®Google Scholar
• Eide N, Walaas L. Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmol. 2009;87(6):588–601. doi:10.1111/j.1755-3768.2009.01637.x.
   PubMed Web of Science ®Google Scholar
• Intzedy L, Teoh SCB, Hogan A, et al. Cytopathological analysis of vitreous in intraocular lymphoma. Eye. 2008;22(2):289–293. doi:10.1038/sj.eye.6702965.
   PubMed Web of Science ®Google Scholar
• Svozilkova P, Heissigerova J, Brichova M, Kalvodova B, Dvorak J, Rihova E. The role of pars plana vitrectomy in the diagnosis and treatment of uveitis. Eur J Ophthalmol. 2011;21(1):89–97. doi:10.5301/EJO.2010.4040.
   PubMed Web of Science ®Google Scholar
• Garweg JG, Wanner D, Sarra GM, et al. The diagnostic yield of vitrectomy specimen analysis in chronic idiopathic endogenous uveitis. Eur J Ophthalmol. 2006;16(4):588–594. doi:10.1177/112067210601600414.
   PubMed Web of Science ®Google Scholar
• Ortega-Larrocea G, Bobadilla-Del-Valle M, Ponce-De-León A, Sifuentes-Osornio J. Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. Arch Med Res. 2003;34(2):116–119. doi:10.1016/S0188-4409(02)00467-8.
   PubMed Web of Science ®Google Scholar
• Lohmann CP, Linde HJ, Reischl U. Improved detection of microorganisms by polymerase chain reaction in delayed endophthalmitis after cataract surgery. Ophthalmology. 2000;107(6). doi:10.1016/S0161-6420(00)00083-X.
   Web of Science ®Google Scholar
• Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. September 9, 2010;363(11):1005–1015. doi:10.1056/NEJMoa0907847.
   PubMed Web of Science ®Google Scholar
• Lawn SD, Nicol MP. Xpert ® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol.September, 2011;6(9):1067–1082. doi:10.2217/fmb.11.84.
   PubMed Web of Science ®Google Scholar
• Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. November 1, 2008;32(5):1165–1174. doi:10.1183/09031936.00061808.
   PubMed Web of Science ®Google Scholar
• Albert H, Bwanga F, Mukkada S, et al. Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis. December 26, 2010;10(1):41. doi:10.1186/1471-2334-10-41.
   PubMedGoogle Scholar
• Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology. 2004;111(9):1762–1767. doi:10.1016/j.ophtha.2004.03.021.
   PubMed Web of Science ®Google Scholar
• Fend F, Ferreri AJM, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173(5):680–692. doi:10.1111/bjh.14025.
   PubMed Web of Science ®Google Scholar
• Merle-Béral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol. 2004;124(4):469–473. doi:10.1046/j.1365-2141.2003.04800.x.
   PubMed Web of Science ®Google Scholar